Circulating Endotrophin Predicts Myocardial Fibrosis Burden and Is Sensitive to Antifibrotic Therapy.
Saved in:
| Title: | Circulating Endotrophin Predicts Myocardial Fibrosis Burden and Is Sensitive to Antifibrotic Therapy. |
|---|---|
| Authors: | Black N; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Lewis G; Liverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Liverpool, United Kingdom., Soltani F; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Dodd S; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom., Williams SG; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom., Schelbert EB; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Laursen C; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Nordic Bioscience A/S, Herlev, Denmark., Angeli E; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Nordic Bioscience A/S, Herlev, Denmark., Reese-Petersen AL; Nordic Bioscience A/S, Herlev, Denmark., Karsdal M; Nordic Bioscience A/S, Herlev, Denmark., Genovese F; Nordic Bioscience A/S, Herlev, Denmark., Miller CA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom. Electronic address: Christopher.miller@manchester.ac.uk. |
| Source: | JACC. Advances [JACC Adv] 2026 May; Vol. 5 (5), pp. 102738. Date of Electronic Publication: 2026 Apr 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42000551 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating Endotrophin Predicts Myocardial Fibrosis Burden and Is Sensitive to Antifibrotic Therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Black+N%22">Black N</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lewis+G%22">Lewis G</searchLink>; Liverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Soltani+F%22">Soltani F</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dodd+S%22">Dodd S</searchLink>; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Williams+SG%22">Williams SG</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schelbert+EB%22">Schelbert EB</searchLink>; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Laursen+C%22">Laursen C</searchLink>; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Angeli+E%22">Angeli E</searchLink>; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Reese-Petersen+AL%22">Reese-Petersen AL</searchLink>; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Karsdal+M%22">Karsdal M</searchLink>; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Genovese+F%22">Genovese F</searchLink>; Nordic Bioscience A/S, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Miller+CA%22">Miller CA</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom; Manchester University NHS Foundation Trust, Manchester, United Kingdom. Electronic address: Christopher.miller@manchester.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918419284106676%22">JACC. Advances</searchLink> [JACC Adv] 2026 May; Vol. 5 (5), pp. 102738. <i>Date of Electronic Publication: </i>2026 Apr 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918419284106676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2772-963X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222772963X%22">2772963X </searchLink><i>NLM ISO Abbreviation: </i>JACC Adv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42000551 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jacadv.2026.102738 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102738 Titles: – TitleFull: Circulating Endotrophin Predicts Myocardial Fibrosis Burden and Is Sensitive to Antifibrotic Therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Black N – PersonEntity: Name: NameFull: Lewis G – PersonEntity: Name: NameFull: Soltani F – PersonEntity: Name: NameFull: Dodd S – PersonEntity: Name: NameFull: Williams SG – PersonEntity: Name: NameFull: Schelbert EB – PersonEntity: Name: NameFull: Laursen C – PersonEntity: Name: NameFull: Angeli E – PersonEntity: Name: NameFull: Reese-Petersen AL – PersonEntity: Name: NameFull: Karsdal M – PersonEntity: Name: NameFull: Genovese F – PersonEntity: Name: NameFull: Miller CA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2772-963X Numbering: – Type: volume Value: 5 – Type: issue Value: 5 Titles: – TitleFull: JACC. Advances Type: main |
| ResultId | 1 |